BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26582376)

  • 21. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.
    Heuser M; Argiropoulos B; Kuchenbauer F; Yung E; Piper J; Fung S; Schlenk RF; Dohner K; Hinrichsen T; Rudolph C; Schambach A; Baum C; Schlegelberger B; Dohner H; Ganser A; Humphries RK
    Blood; 2007 Sep; 110(5):1639-47. PubMed ID: 17494859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.
    Goyama S; Kurokawa M
    Cancer Sci; 2009 Jun; 100(6):990-5. PubMed ID: 19385966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All-Trans Retinoic Acid Synergizes with Enasidenib to Induce Differentiation of IDH2-Mutant Acute Myeloid Leukemia Cells.
    Kim Y; Jeung HK; Cheong JW; Song J; Bae SH; Lee JI; Min YH
    Yonsei Med J; 2020 Sep; 61(9):762-773. PubMed ID: 32882760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salt-inducible kinase inhibition sensitizes human acute myeloid leukemia cells to all-trans retinoic acid-induced differentiation.
    Zhang XW; Shen X; Long WY; Xiao H; Li FJ; Xing S; Xiong GL; Yu ZY; Cong YW
    Int J Hematol; 2021 Feb; 113(2):254-262. PubMed ID: 33074481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment.
    Su M; Alonso S; Jones JW; Yu J; Kane MA; Jones RJ; Ghiaur G
    PLoS One; 2015; 10(6):e0127790. PubMed ID: 26047326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model.
    Watanabe-Okochi N; Yoshimi A; Sato T; Ikeda T; Kumano K; Taoka K; Satoh Y; Shinohara A; Tsuruta T; Masuda A; Yokota H; Yatomi Y; Takahashi K; Kitaura J; Kitamura T; Kurokawa M
    Blood; 2013 May; 121(20):4142-55. PubMed ID: 23547050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis.
    Ying M; Zhou X; Zhong L; Lin N; Jing H; Luo P; Yang X; Song H; Yang B; He Q
    Mol Cancer Ther; 2013 Feb; 12(2):195-206. PubMed ID: 23243061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostat.
    Blagitko-Dorfs N; Jiang Y; Duque-Afonso J; Hiller J; Yalcin A; Greve G; Abdelkarim M; Hackanson B; Lübbert M
    PLoS One; 2013; 8(10):e75258. PubMed ID: 24116031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia.
    Su G; Lian X; Tan D; Tao H; Liu H; Chen S; Yin H; Wu D; Yin B
    Leuk Lymphoma; 2015 Feb; 56(2):472-9. PubMed ID: 24828867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGFBP7 activates retinoid acid-induced responses in acute myeloid leukemia stem and progenitor cells.
    van Gils N; Verhagen HJMP; Rutten A; Menezes RX; Tsui ML; Vermue E; Dekens E; Brocco F; Denkers F; Kessler FL; Ossenkoppele GJ; Janssen JJWM; Smit L
    Blood Adv; 2020 Dec; 4(24):6368-6383. PubMed ID: 33351133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of EVI-1 in normal hematopoiesis and myeloid malignancies (Review).
    Yuan X; Wang X; Bi K; Jiang G
    Int J Oncol; 2015 Dec; 47(6):2028-36. PubMed ID: 26496831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiation.
    van Gils N; Verhagen HJMP; Smit L
    Exp Hematol; 2017 Aug; 52():12-23. PubMed ID: 28456748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemia.
    Rice AM; Holtz KM; Karp J; Rollins S; Sartorelli AC
    Leuk Res; 2004 Nov; 28(11):1227-37. PubMed ID: 15380350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The autophagy scaffold protein ALFY is critical for the granulocytic differentiation of AML cells.
    Schläfli AM; Isakson P; Garattini E; Simonsen A; Tschan MP
    Sci Rep; 2017 Oct; 7(1):12980. PubMed ID: 29021535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
    Nishioka C; Ikezoe T; Yang J; Gery S; Koeffler HP; Yokoyama A
    Int J Cancer; 2009 Oct; 125(7):1710-20. PubMed ID: 19507250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2.
    Britschgi A; Simon HU; Tobler A; Fey MF; Tschan MP
    Br J Haematol; 2010 Apr; 149(1):55-64. PubMed ID: 20096012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zinc finger transcription factor ecotropic viral integration site 1 is induced by all-trans retinoic acid (ATRA) and acts as a dual modulator of the ATRA response.
    Bingemann SC; Konrad TA; Wieser R
    FEBS J; 2009 Nov; 276(22):6810-22. PubMed ID: 19843176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Clin Cancer Res; 2016 Mar; 22(5):1211-21. PubMed ID: 26459180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells.
    Eguchi-Ishimae M; Eguchi M; Ohyashiki K; Yamagata T; Mitani K
    Int J Hematol; 2009 Mar; 89(2):253-256. PubMed ID: 19241117
    [No Abstract]   [Full Text] [Related]  

  • 40. GSK3 is a regulator of RAR-mediated differentiation.
    Gupta K; Gulen F; Sun L; Aguilera R; Chakrabarti A; Kiselar J; Agarwal MK; Wald DN
    Leukemia; 2012 Jun; 26(6):1277-85. PubMed ID: 22222598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.